InflaRx (IFRX) Gross Profit (2023 - 2025)

Historic Gross Profit for InflaRx (IFRX) over the last 3 years, with Q3 2025 value amounting to -$202102.7.

  • InflaRx's Gross Profit fell 19371.28% to -$202102.7 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 billion, marking a year-over-year decrease of 150768587.47%. This contributed to the annual value of -$3.4 million for FY2024, which is 57565.47% down from last year.
  • Latest data reveals that InflaRx reported Gross Profit of -$202102.7 as of Q3 2025, which was down 19371.28% from -$2.7 million recorded in Q2 2025.
  • InflaRx's 5-year Gross Profit high stood at $215661.8 for Q3 2024, and its period low was -$9.8 billion during Q1 2025.
  • Over the past 3 years, InflaRx's median Gross Profit value was -$295732.9 (recorded in 2023), while the average stood at -$1.1 billion.
  • Per our database at Business Quant, InflaRx's Gross Profit surged by 20195.46% in 2024 and then tumbled by 487627675.63% in 2025.
  • Quarter analysis of 3 years shows InflaRx's Gross Profit stood at -$295732.9 in 2023, then tumbled by 919.46% to -$3.0 million in 2024, then soared by 93.3% to -$202102.7 in 2025.
  • Its Gross Profit was -$202102.7 in Q3 2025, compared to -$2.7 million in Q2 2025 and -$9.8 billion in Q1 2025.